FDA Approves Remicade Biosimilar (Inflectra)FDA Approves Remicade Biosimilar (Inflectra)

The second biosimilar approved in the United States, this version of infliximab is indicated for Crohn's disease, rheumatoid arthritis, and almost all other conditions listed for the original. FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Internal Medicine News Alert Source Type: news